Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level.

Warnnissorn, Naree; Kanitsap, Nonglak; Niparuck, Pimjai; Boonsakan, Paisarn; Kulalert, Prapasri; Limvorapitak, Wasithep; Bhoopat, Lantarima; Saengboon, Supawee; Suriyonplengsaeng, Chinnawut; Chantrathammachart, Pichika; Puavilai, Teeraya; Chuncharunee, Suporn.

Affiliation

Warnnissorn N; Department of Pathology, Faculty of Medicine, Thammasat University, Pathumthani, Thailand. nareeaw@tu.ac.th.
Kanitsap N; Division of Hematology, Department of Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
Niparuck P; Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Boonsakan P; Department of Pathology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Kulalert P; Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
Limvorapitak W; Division of Hematology, Department of Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
Bhoopat L; Division of Hematology, Department of Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
Saengboon S; Division of Hematology, Department of Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
Suriyonplengsaeng C; Department of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand.
Chantrathammachart P; Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Puavilai T; Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Chuncharunee S; Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.